These generic gemcitabine injections are therapeutic equivalents of Eli Lilly’s Gemzar injections available in two strengths: 200mg and 1g single use vial. Gemcitabine is an anticancer agent, used
Power3 Medical has determined the blood serum concentrations of these forty-seven biomarkers in samples from more than 750 neurodegenerative disease patients and normal control subjects. The results have
Celgene is solely responsible for the funding and management of development and commercialization of this inflammatory disease candidate. Pharmacopeia currently receives an annual license fee from Celgene for
The initial Phase I study, which will be performed by the Children’s Oncology Group (COG) Phase I Consortium that includes 20 clinical COG sites in North America, will
The Commission amended the information regarding SmPCs, dosage adjustments, Posology and method of administration, and therapeutic indication for Aranesp. The CHMP granted positive opinions for all centrally-authorized erythropoiesis
QuantRx and Jant are exploring quantitative point of care technologies in areas of oncology, cardiovascular, and other emerging markets. The technologies are supported by strong IP positions as
The Phase II trial will be an international, multi-centre, randomized, controlled, open label study assessing the efficacy and safety of CTCE-9908 that will include up to 123 patients.
The survey found that many people bought prescription-drugs under the influence of the drug ads, which they otherwise would not have bought. The poll also found that 82%
The budget has reduced customs duty from 15% to 10% for some live-saving medicines and the bulk drugs used in their manufacture, and also exempted them from excise
The PCA3 test measures the expression of prostate cancer gene 3 (PCA3) mRNA in urine samples. PCA3 is specific to the prostate and is significantly up-regulated (60-100 fold)
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.